Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Who we are. Novo Nordisk may share reported complaints and side effects with health authorities as mandated by law, regulation or as required by court order. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Who we are. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Ново Нордиск е водещата компания в света за производство на инсулин и медикаменти в областта на диабета. address: Bulgaria, Sofia 1407 street: Lozenetz, Zlaten rog 20, fl. Novo Nordisk will retain the data consistent with Novo Nordisk’s data retention policies and as long as required by law. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk's history Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk A/S: ClinicalTrials.gov Identifier: NCT03689374 Other Study ID Numbers: NN9535-4386 U1111-1200-0164 ( Other Identifier: World Health Organization (WHO) ) 2017-003219-20 ( Registry Identifier: EudraCT ) First Posted: September 28, 2018 Key … Who we are.

Диабет. Novo Nordisk Pharma EAD. Novo Nordisk A/S: ClinicalTrials.gov Identifier: NCT03989232 Other Study ID Numbers: NN9535-4506 U1111-1224-5162 ( Other Identifier: World Health Organization (WHO) ) 2018-004529-96 ( Registry Identifier: European Medicines Agency (EudraCT) ) First Posted: June 18, 2019 Key Record Dates: Last Update Posted: Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. 8 phone: +359 2 962 74 71 fax: +359 2 962 55 72 email: officebg@novonordisk.com The story of Novo Nordisk goes back more than 90 years It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.